Latest stories on RAPP
BTIG Raises its Price Target on Rapport Therapeutics (RAPP)
Yahoo Top61 · neutralanalyst
RAPP Advances RAP-219 Into Phase 3, Raising the Stakes in Focal Epilepsy
TipRanks67 · bullishproduct/pr
RAPP news roundup. 2 stories in the past week, 3 over 30 days. Average 30-day sentiment is 60.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $17.2M — net selling of $17.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.